Form Type: 4

Accession Number:0001225208-22-000115
Original Submission Date:

Reporting Person:

MARLBOROUGH, MA 01752-1234

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-01-01 M 6,175 a $0.00 173,752 direct
COMMON STOCK 2022-01-01 F 2,346 d $42.48 171,406 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
PERFORMANCE SHARE UNITS 0.0 2022-01-01 deemed execution date M 6,175 (d) 2021-12-31 2021-12-31 common stock 6,175 $0.00 0 direct
f1 on february 21, 2019, the reporting person was awarded a target number of performance share units under the company's 2019 free cash flow performance share program, the actual number of which to be earned by the reporting person would be based on the company's 2019 adjusted free cash flow measured against its 2019 financial plan over the one-year performance period ending december 31, 2019 and subject to the completion of a three-year individual service period (inclusive of the performance period). on february 24, 2020, the number of the target performance share units as to which the performance criteria had been satisfied was determined. the performance share units so determined vested in whole upon completion of the individual service period that ended on december 31, 2021.
f2 includes shares acquired under the boston scientific global employee stock purchase plan based upon the most current data available.
f3 each performance share unit represents the company's commitment to issue one share of boston scientific common stock.

Elevate your investments